{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:10:31Z","timestamp":1791331831448,"version":"4.3.1"},"reference-count":129,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.clindermatol.2017.10.008","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T07:21:03Z","timestamp":1507965663000},"page":"167-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"title":["Epidemiology of skin cancer in the mature patient"],"prefix":"10.1016","volume":"36","author":[{"given":"Vivien","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Cranwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2017.10.008_bb0005","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0190-9622(88)70270-4","article-title":"Skin cancer in a Queensland population","volume":"19","author":"Green","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1067\/mjd.2000.103342","article-title":"Epidemiology of actinic keratoses and squamous cell carcinoma","volume":"42","author":"Salasche","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.5694\/j.1326-5377.1990.tb124456.x","article-title":"The role of childhood exposure to sunlight in the development of solar keratoses and non-melanocytic skin cancer","volume":"152","author":"Marks","year":"1990","journal-title":"Med J Aust"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0020","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/1523-1747.ep12395643","article-title":"Aberrations of the tumor suppressor p53 gene and p53 protein in solar keratosis in human skin","volume":"103","author":"Taguchi","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1684\/ejd.2009.0706","article-title":"Predisposing factors of actinic keratosis in a North-West German population","volume":"19","author":"Hensen","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0030","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1056\/NEJM199310143291602","article-title":"Reduction of solar keratoses by regular sunscreen use","volume":"329","author":"Thompson","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0035","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/jid.2013.134","article-title":"Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study","volume":"133","author":"Flohil","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0040","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1365-2133.1998.02560.x","article-title":"The prevalence and determinants of solar keratoses at a subtropical latitude (Queensland, Australia)","volume":"139","author":"Frost","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0045","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(84)92221-9","article-title":"Cancer, warts, and sunshine in renal transplant patients. A case-control study","volume":"1","author":"Boyle","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0050","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(88)91658-3","article-title":"Malignant transformation of solar keratoses to squamous cell carcinoma","volume":"1","author":"Marks","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0055","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/cncr.24284","article-title":"Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial","volume":"115","author":"Criscione","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.146.s61.2.x","article-title":"The epidemiology of skin cancer","volume":"146","author":"Diepgen","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2133.2007.08273.x","article-title":"Epidemiology and aetiology of basal cell carcinoma","volume":"157","author":"Roewert-Huber","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0070","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0190-9622(96)90114-0","article-title":"Increased proportion of aggressive-growth basal cell carcinoma in the Veterans Affairs population of Palo Alto, California","volume":"35","author":"Wrone","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0075","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0190-9622(93)70165-P","article-title":"Basal cell carcinoma in Kauai, Hawaii: The highest documented incidence in the United States","volume":"29","author":"Reizner","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0080","series-title":"NIH Publication No 83-2433, US Dept of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, Bethesda, MD","article-title":"Incidence of Nonmelanoma Skin Cancer in the United States in Collaboration with Fred Hutchinson Cancer Research Center","author":"Scotto","year":"1983"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0085","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jama.294.6.681","article-title":"Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years","volume":"294","author":"Christenson","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0090","series-title":"Basal cell carcinoma in Australia","author":"Sharma","year":"2013"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0095","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1111\/jdv.13703","article-title":"Epidemiology of basal and squamous cell carcinoma in Belgium: The need for a uniform and compulsory registration","volume":"30","author":"Callens","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0100","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archderm.135.7.781","article-title":"Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995","volume":"135","author":"Hannuksela-Svahn","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0190-9622(90)70056-N","article-title":"Basal cell carcinoma. A population-based incidence study in Rochester, Minnesota","volume":"22","author":"Chuang","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0110","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/oxfordjournals.aje.a008875","article-title":"Skin cancer in a subtropical Australian population: Incidence and lack of association with occupation","volume":"144","author":"Green","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2133.2006.07234.x","article-title":"Basal cell carcinoma: Histological classification and body-site distribution","volume":"155","author":"Raasch","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ajd.12202","article-title":"Basal cell carcinoma in Singapore: A prospective study on epidemiology and clinicopathological characteristics with a secondary comparative analysis between Singaporean Chinese and Caucasian patients","volume":"56","author":"Tan","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0125","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ijc.2910600411","article-title":"Does intermittent sun exposure cause basal cell carcinoma? A case-control study in Western Australia","volume":"60","author":"Kricker","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0130","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/sj.bjc.6602982","article-title":"Comparison of risk patterns in carcinoma and melanoma of the skin in men: A multi-centre case-case-control study","volume":"94","author":"Zanetti","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/archderm.1995.01690140041006","article-title":"Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma","volume":"131","author":"Gallagher","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/oxfordjournals.aje.a010034","article-title":"Risk factors for basal cell carcinoma of the skin in men: Results from the health professionals follow-up study","volume":"150","author":"van Dam","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0145","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jaad.2011.11.940","article-title":"Indoor tanning and risk of early-onset basal cell carcinoma","volume":"67","author":"Ferrucci","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0150","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1542\/peds.2013-3559","article-title":"Early-onset basal cell carcinoma and indoor tanning: A population-based study","volume":"134","author":"Karagas","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5909","article-title":"Indoor tanning and non-melanoma skin cancer: Systematic review and meta-analysis","volume":"345","author":"Wehner","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0160","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/jnci\/90.17.1278","article-title":"Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA follow-up study","volume":"90","author":"Stern","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0165","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1038\/jid.2013.144","article-title":"Photosensitizing agents and the risk of non-melanoma skin cancer: A population-based case-control study","volume":"133","author":"Makhzoumi","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0170","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0175","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/ijc.24439","article-title":"Cancer incidence and risk factors after solid organ transplantation","volume":"125","author":"Vajdic","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0180","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jnci\/djs529","article-title":"HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer","volume":"105","author":"Silverberg","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0185","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1158\/0008-5472.CAN-09-0415","article-title":"CTLA4 variants, UV-induced tolerance, and risk of non-melanoma skin cancer","volume":"69","author":"Welsh","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0190","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.canep.2015.09.005","article-title":"Family history of skin cancer is associated with early-onset basal cell carcinoma independent of MC1R genotype","volume":"39","author":"Berlin","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0195","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaad.2008.09.035","article-title":"Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986-2006","volume":"60","author":"Fine","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0200","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ejca.2005.08.042","article-title":"Skin cancer in survivors of childhood and adolescent cancer","volume":"42","author":"Levi","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0205","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/archdermatol.2012.1374","article-title":"Smoking and the risk of nonmelanoma skin cancer: Systematic review and meta-analysis","volume":"148","author":"Leonardi-Bee","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0210","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0190-9622(84)80334-5","article-title":"Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature","volume":"10","author":"von Domarus","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2133.2006.07610.x","article-title":"Morton CA; Therapy Guidelines and Audit Subcommittee, British Association of Dermatologists. Guidelines for management of Bowen\u2019s disease: 2006 update","volume":"156","author":"Cox","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0220","first-page":"878","article-title":"Bowen\u2019s disease: A four-year retrospective review of epidemiology and treatment at a university center","volume":"34","author":"Hansen","year":"2008","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0225","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/lsm.20329","article-title":"Measurement of protection afforded by ultraviolet-absorbing window film using an in vitro model of photodamage","volume":"38","author":"Bernstein","year":"2006","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0230","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0190-9622(92)70208-W","article-title":"Cutaneous Bowen\u2019s disease. An analysis of 1001 cases according to age, sex, and site","volume":"27","author":"Kossard","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0235","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1002\/ijc.25411","article-title":"Trends in the incidence of nonmelanoma skin cancer in Denmark 1978-2007: Rapid incidence increase among young Danish women","volume":"127","author":"Birch-Johansen","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0240","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R","article-title":"Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group","volume":"81","author":"Karagas","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0245","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archderm.1997.03890420073008","article-title":"Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992","volume":"133","author":"Gray","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0250","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jaad.2005.08.063","article-title":"Skin cancer in skin of color","volume":"55","author":"Gloster","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0255","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1011-1344(01)00198-1","article-title":"The epidemiology of UV induced skin cancer","volume":"63","author":"Armstrong","year":"2001","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0260","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/archderm.1980.01640280090030","article-title":"The relative importance of risk factors in nonmelanoma carcinoma","volume":"116","author":"Vitaliano","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0265","doi-asserted-by":"crossref","first-page":"10124","DOI":"10.1073\/pnas.88.22.10124","article-title":"A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma","volume":"88","author":"Brash","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0270","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/bjc.1996.274","article-title":"The multicentre south European study \u2018Helios\u2019. I: Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin","volume":"73","author":"Zanetti","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.125579","article-title":"Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management","volume":"47","author":"Berg","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0280","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1111\/j.1600-6143.2008.02386.x","article-title":"Skin cancer in organ transplant recipients\u2014where do we stand today?","volume":"8","author":"Ulrich","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0285","first-page":"e383","article-title":"Epidemiology and clinical evolution of non-melanoma skin cancer in renal transplant recipients: A single-center experience in S\u00e3o Paulo, Brazil","volume":"54","author":"Hayashida","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0290","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00007890-199003000-00006","article-title":"Incidence of skin cancer after renal transplantation in The Netherlands","volume":"49","author":"Hartevelt","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0295","first-page":"413","article-title":"Cancers arising from burn scars: 62 cases","volume":"130","author":"Jellouli-Elloumi","year":"2003","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0300","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-2133.2003.05376.x","article-title":"A broad spectrum of human papillomavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis","volume":"149","author":"Forslund","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0305","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jamadermatol.2015.4530","article-title":"Association between \u03b2-genus human papillomavirus and cutaneous squamous cell carcinoma in immunocompetent individuals\u2014a meta-analysis","volume":"152","author":"Chahoud","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0310","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/jid.2011.91","article-title":"Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma","volume":"131","author":"Arron","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0315","doi-asserted-by":"crossref","first-page":"E1173","DOI":"10.1002\/ijc.27581","article-title":"Next-generation sequencing fails to identify human virus sequences in cutaneous squamous cell carcinoma","volume":"131","author":"Ganzenmueller","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0320","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/DSS.0000000000000292","article-title":"Family history of skin cancer is associated with increased risk of cutaneous squamous cell carcinoma","volume":"41","author":"Asgari","year":"2015","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0325","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajmg.c.30037","article-title":"The genetics of skin cancer","volume":"131C","author":"Tsai","year":"2004","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0330","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/CCO.0b013e3283436e8c","article-title":"RAF inhibition and induction of cutaneous squamous cell carcinoma","volume":"23","author":"Robert","year":"2011","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0335","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/ng.3091","article-title":"Recurrent point mutations in the kinetochore gene KNSTRN in cutaneous squamous cell carcinoma","volume":"46","author":"Lee","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0340","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1105358","article-title":"RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors","volume":"366","author":"Su","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0345","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaad.2009.09.033","article-title":"Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole","volume":"62","author":"Cowen","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0350","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/aje\/153.6.559","article-title":"Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study","volume":"153","author":"Karagas","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0355","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/ijc.21156","article-title":"Histologic characteristics of skin cancer in Hiroshima and Nagasaki: Background incidence and radiation effects","volume":"117","author":"Kishikawa","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0360","first-page":"326","article-title":"Keratoacanthoma: A clinico-pathologic enigma","volume":"30","author":"Schwartz","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0365","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1445-2197.2010.05219.x","article-title":"Keratoacanthoma: Is it really a variant of squamous cell carcinoma?","volume":"80","author":"Weedon","year":"2010","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0370","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1067\/mjd.2003.114","article-title":"Keratoacanthoma developing in sites of previous trauma: A report of two cases and review of the literature","volume":"48","author":"Pattee","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0375","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-4632.2007.03260.x","article-title":"Keratoacanthoma: A tumor in search of a classification","volume":"46","author":"Karaa","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0380","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.clindermatol.2009.06.010","article-title":"Keratoacanthoma: Facts and controversies","volume":"28","author":"Ko","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0385","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D32WT2T8HM","article-title":"Association between solitary keratoacanthoma and cigarette smoking: A case-control study","volume":"12","author":"Miot","year":"2006","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0390","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0395","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1634\/theoncologist.2012-0333","article-title":"Analysis of dermatologic events in vemurafenib-treated patients with melanoma","volume":"18","author":"Lacouture","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0400","series-title":"SEER Cancer Statistics Review","author":"National Cancer Institute","year":"1975"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0405","doi-asserted-by":"crossref","first-page":"djv048","DOI":"10.1093\/jnci\/djv048","article-title":"Annual report to the nation on the status of cancer, 1975-2011, featuring incidence of breast cancer subtypes by race\/ethnicity, poverty, and state","volume":"107","author":"Kohler","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0410","series-title":"Cancer Incidence and Mortality Worldwide in 2008","article-title":"GLOBOCAN 2008","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0415","first-page":"591","article-title":"Centers for Disease Control and Prevention (CDC). Vital signs: Melanoma incidence and mortality trends and projections\u2014United States, 1982-2030","volume":"64","author":"Guy","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2011.04.032","article-title":"Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006","volume":"65","author":"Jemal","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0425","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1467-842X.2005.tb00211.x","article-title":"Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control","volume":"29","author":"Baade","year":"2005","journal-title":"Aust NZJ Public Health"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0430","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/bjc.2012.22","article-title":"Skin cancer screening participation and impact on melanoma incidence in Germany\u2014an observational study on incidence trends in regions with and without population-based screening","volume":"106","author":"Waldmann","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0435","first-page":"20","article-title":"Death rates of malignant melanoma among white men\u2014United States, 1973-1988","volume":"41","author":"Centers for Disease Control (CDC)","year":"1992","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0440","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/cncr.10855","article-title":"Strategies for improving melanoma education and screening for men age \u226550 years","volume":"95","author":"Geller","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0445","doi-asserted-by":"crossref","first-page":"e3315","DOI":"10.1097\/MD.0000000000003315","article-title":"Association between race\/ethnicity and survival of melanoma patients in the United States over 3 decades: A secondary analysis of SEER data","volume":"95","author":"Ward-Peterson","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0450","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R","article-title":"Melanoma and sun exposure: An overview of published studies","volume":"73","author":"Elwood","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0455","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/ncomms1893","article-title":"Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment","volume":"3","author":"Noonan","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0460","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/ijc.22453","volume":"120","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0465","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF01830242","article-title":"Latitude gradients in melanoma incidence and mortality in the non-Maori population of New Zealand","volume":"5","author":"Bulliard","year":"1994","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0470","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.ejca.2005.03.034","article-title":"Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors","volume":"41","author":"Gandini","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0475","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/jnci\/djh136","article-title":"Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families","volume":"96","author":"Chaudru","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0480","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0140-6736(04)15649-3","article-title":"Is there more than one road to melanoma?","volume":"363","author":"Rivers","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0485","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/CMR.0b013e32831c6fe7","article-title":"Time trends in tumour thickness vary in subgroups: analysis of 6475 patients by age, tumour site and melanoma subtype","volume":"19","author":"Baumert","year":"2009","journal-title":"Melanoma Res"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0490","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1136\/jmg.15.5.352","article-title":"Familial atypical multiple mole-melanoma syndrome","volume":"15","author":"Mize","year":"1978","journal-title":"J Med Genet"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0495","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMcp023017","article-title":"Clinical practice. Dysplastic nevi","volume":"349","author":"Naeyaert","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0500","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archdermatol.2010.2","article-title":"Increased risk of second primary cancers after a diagnosis of melanoma","volume":"146","author":"Bradford","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0505","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/cncr.11116","article-title":"A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors","volume":"97","author":"Goggins","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0510","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1097-0142(19950115)75:2+<707::AID-CNCR2820751415>3.0.CO;2-W","article-title":"Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Screening implications","volume":"75","author":"Marghoob","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0515","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1001\/jama.280.10.910","article-title":"Increased cancer mortality following a history of nonmelanoma skin cancer","volume":"280","author":"Kahn","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0520","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.mayocp.2012.04.018","article-title":"Melanoma in immunosuppressed patients","volume":"87","author":"Kubica","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0525","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archdermatol.2011.159","article-title":"Malignant melanoma in solid transplant recipients: Collection of database cases and comparison with surveillance, epidemiology, and end results data for outcome analysis","volume":"147","author":"Brewer","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0530","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1158\/1055-9965.1042.13.6","article-title":"Diet and melanoma in a case-control study","volume":"13","author":"Millen","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0535","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11010-007-9628-x","article-title":"Caffeine inhibits UV-mediated NF-kappaB activation in A2058 melanoma cells: An ATM-PKCdelta-p38 MAPK-dependent mechanism","volume":"308","author":"Ravi","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0540","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archneurol.2010.1","article-title":"Increased melanoma risk in Parkinson disease: A prospective clinicopathological study","volume":"67","author":"Bertoni","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0545","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1001\/archinte.167.19.2061","article-title":"Personal history of endometriosis and risk of cutaneous melanoma in a large prospective cohort of French women","volume":"167","author":"Kvaskoff","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0550","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1200\/JCO.2013.51.1915","article-title":"Personal history of prostate cancer and increased risk of incident melanoma in the United States","volume":"31","author":"Li","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0555","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.14694\/EdBook_AM.2015.35.e519","article-title":"Merkel cell carcinoma: Emerging biology, current approaches, and future directions","author":"Tothill","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0560","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0190-9622(93)70159-Q","article-title":"Merkel cell carcinoma","volume":"29","author":"Ratner","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/680410","article-title":"Which are the cells of origin in Merkel cell carcinoma?","volume":"2012","author":"Tilling","year":"2012","journal-title":"J Skin Cancer"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0570","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-0560.2009.01370.x","article-title":"Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: A population based study","volume":"27","author":"Albores-Saavedra","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0575","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jamadermatol.2014.124","article-title":"Incidence and survival for Merkel cell carcinoma in Queensland, Australia, 1993-2010","volume":"150","author":"Youlden","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0580","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2133.2011.10493.x","article-title":"Merkel cell carcinoma in Western Australia: A population-based study of incidence and survival","volume":"165","author":"Girschik","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0585","doi-asserted-by":"crossref","first-page":"dju382","DOI":"10.1093\/jnci\/dju382","article-title":"Risk of merkel cell carcinoma after solid organ transplantation","volume":"107","author":"Clarke","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0590","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1158\/1055-9965.EPI-05-0895","article-title":"Merkel cell carcinoma and multiple primary cancers","volume":"15","author":"Howard","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0595","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/apc.2006.0152","article-title":"Merkel cell carcinoma and HIV infection: A case report and review of the literature","volume":"21","author":"Manganoni","year":"2007","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0600","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/annonc\/mdq308","article-title":"Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: An old bond with possible new viral ties","volume":"22","author":"Tadmor","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0605","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","article-title":"Clonal integration of a polyomavirus in human Merkel cell carcinoma","volume":"319","author":"Feng","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0610","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/jnci\/djp332","article-title":"Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma","volume":"101","author":"Carter","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0615","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaad.2007.11.020","article-title":"Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: The AEIOU features","volume":"58","author":"Heath","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0620","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jsbmb.2006.12.030","article-title":"A meta-analysis of second cancers after a diagnosis of nonmelanoma skin cancer: Additional evidence that solar ultraviolet-B irradiance reduces the risk of internal cancers","volume":"103","author":"Grant","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0625","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1158\/1055-9965.EPI-10-0243","article-title":"Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review","volume":"19","author":"Wheless","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0630","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1158\/1055-9965.EPI-13-0902","article-title":"Subsequent primary malignancies in patients with nonmelanoma skin cancer in England: A national record-linkage study","volume":"23","author":"Ong","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0635","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2014.02.007","article-title":"The risk of developing a second primary cancer in melanoma patients: A comprehensive review of the literature and meta-analysis","volume":"75","author":"Caini","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0640","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10552-008-9256-0","article-title":"Impact of socioeconomic status on cancer incidence and stage at diagnosis: Selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study","volume":"20","author":"Clegg","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clindermatol.2017.10.008_bb0645","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/bjd.12694","article-title":"Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009","volume":"170","author":"Jung","year":"2014","journal-title":"Br J Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X17301980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X17301980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T19:40:18Z","timestamp":1719517218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X17301980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":129,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0738081X17301980"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2017.10.008","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of skin cancer in the mature patient","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2017.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}